Press Release

5.8% growth for Veterinary Therapeutics Market by 2025, global revenue to reach $ 54,968.3 Mn

Veterinary Therapeutics Market to Exhibit 5.8% CAGR Driven by Rising Demand for Meat Products, says Fortune Business Insights

In 2017, the global market for veterinary therapeutics was valued at US$ 35,005.2 Mn and is projected to reach a value of US$ 54,968.3 Mn by 2025. Furthermore, the report predicts the global market to expand at a CAGR of 5.8% during the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-therapeutics-market-100138

The Veterinary Therapeutics Market is projected to grow at a significant rate on account of rising demand for meat and meat products. Fortune Business Insights in its new report, titled “Veterinary Therapeutics Market Size, Share and Global Trend by Product Type (Drugs, Vaccines), Animal Type (Companion, Livestock), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) and Geography Forecast till 2025” finds that the growing population across the world is positively impacting the veterinary therapeutics market.

Some of the Main Key Players Covered in the Report:

  • Merck Animal Health
  • Zoetis Inc.
  • Elanco
  • Merial
  • Bayer Pharmaceuticals
  • Bayer
  • Boehringer Ingelheim
  • CEVA LogisticsVetoquinol S.A.
  • IDEXX
  • Virbac

Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-therapeutics-market-100138

Table of Content:

1.Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2.Executive Summary

3.Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4.Key Insights

4.1 Pipeline Analysis

4.2 Regulatory Scenario for Key Countries

4.3 Pricing Analysis

4.4 Key Industry Developments

4.5 Overview of Animal Diseases by Key Countries

4.6 Snapshot on the Novel & Upcoming Therapies

4.7 Overview of Treatment Plans for Different Animal Diseases

4.8 Overview of Incidence & Prevalence of Animal Diseases

Increasing Access to Treatment for Companion Animals to Propel the Market

“The increasing research and development (R&D) activities in the veterinary therapeutics area will create ample opportunities for the market’s growth,” stated a lead analyst at Fortune Business Insights. “This has further resulted in the discovery of novel treatment and surgical capabilities for companion animals, which will positively impact the market’s growth,” he added. Also, the rising population across the world, combined with rising demand for food, will act as a chief growth driver of the global veterinary therapeutics market.

Secondary Research Is Conducted To Derive The Following Information

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.

In addition to this, fast approval on new products is also driving the therapeutic drugs segment. However, increasing number of restrictions on the use of antibiotics may offset the segment’s growth. Vaccines are also projected to gain popularity among other veterinary therapeutic products in the upcoming years. The rising need for treating diseases in animals is the major factor driving this segment. Among regions, North America is expected to lead the global veterinary therapeutics market.

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close